These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7271865)

  • 21. Some chemical and biochemical aspects of liver microsomal metabolism of tamoxifen.
    Ruenitz PC; Bagley JR; Pape CW
    Drug Metab Dispos; 1984; 12(4):478-83. PubMed ID: 6148216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural forms of phenprocoumon and warfarin that are metabolized at the active site of CYP2C9.
    He M; Korzekwa KR; Jones JP; Rettie AE; Trager WF
    Arch Biochem Biophys; 1999 Dec; 372(1):16-28. PubMed ID: 10562412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the activation of hepatic microsomal hydroxylation by betamethasone and alpha naphthoflavone.
    Benford DJ; Bridges JW
    Biochem Pharmacol; 1980 Sep; 29(17):2345-9. PubMed ID: 7426041
    [No Abstract]   [Full Text] [Related]  

  • 24. Formation of (4R)- and (4S)-4-hydroxyochratoxin A from ochratoxin A by liver microsomes from various species.
    Størmer FC; Hansen CE; Pedersen JI; Hvistendahl G; Aasen AJ
    Appl Environ Microbiol; 1981 Dec; 42(6):1051-6. PubMed ID: 7316512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The monooxygenation of N-heptane by rat liver microsomes.
    Frommer U; Ullrich V; Staudinger H; Orrenius S
    Biochim Biophys Acta; 1972 Dec; 280(4):487-94. PubMed ID: 4405405
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of dimethylbiguanide on phenprocoumon elimination and its mode of action. A drug interaction study.
    Ohnhaus EE; Berger W; Duckert F; Oesch F
    Klin Wochenschr; 1983 Sep; 61(17):851-8. PubMed ID: 6632727
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of the phenothiazine drug perazine by liver and lung microsomes from various species.
    Breyer U
    Biochem Pharmacol; 1971 Dec; 20(12):3341-51. PubMed ID: 4399893
    [No Abstract]   [Full Text] [Related]  

  • 28. Formation of (4R)- and (4S)-4-hydroxyochratoxin A and 10-hydroxyochratoxin A from Ochratoxin A by rabbit liver microsomes.
    Størmer FC; Støren O; Hansen CE; Pedersen JI; Aasen AJ
    Appl Environ Microbiol; 1983 Apr; 45(4):1183-7. PubMed ID: 6859843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative studies on hepatic N- and O-demethylation.
    Otsuji H; Imamura T; Ikeda M
    Jpn J Pharmacol; 1972 Aug; 22(4):561-70. PubMed ID: 4539508
    [No Abstract]   [Full Text] [Related]  

  • 30. A stable isotope assay for phenprocoumon and its metabolites.
    Heimark LD; Trager WF
    Biomed Mass Spectrom; 1985 Feb; 12(2):67-71. PubMed ID: 3158358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical and biochemical characteristics of O-demethylation of chlorotrianisene in the rat.
    Ruenitz PC; Toledo MM
    Biochem Pharmacol; 1981 Aug; 30(16):2203-7. PubMed ID: 7295335
    [No Abstract]   [Full Text] [Related]  

  • 32. Factors influencing the microsomal metabolism of 3H-reserpine.
    Stawarz RJ; Stitzel RE
    Pharmacology; 1974; 11(3):178-91. PubMed ID: 4151612
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic N-demethylation of 1,3-bis[[1-cycloheptyl-3-(p- dimethylaminophenyl)ureido]methyl]benzene dihydrochloride, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Uchida T; Usui T; Teramura T; Watanabe T; Higuchi S
    Drug Metab Dispos; 1993; 21(3):524-9. PubMed ID: 8100510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biotransformation of phenprocoumon in the rat.
    Pohl LR; Haddock RE; Trager WF
    J Med Chem; 1975 May; 18(5):519-23. PubMed ID: 1151963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microsomal conversion of SKF 525-A and SKF 8742-A.
    Barber PJ; Wilson BJ
    Biochem Pharmacol; 1980 Oct; 29(19):2577-82. PubMed ID: 7426063
    [No Abstract]   [Full Text] [Related]  

  • 37. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine.
    de Vries JX; Völker U
    J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of microsomal pathways of oxidation of alcohols and hydroxyl radical scavenging agents with carbon monoxide and cobalt protoporphyrin IX.
    Krikun G; Cederbaum AI
    Biochem Pharmacol; 1985 Aug; 34(16):2929-35. PubMed ID: 2992522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Influence of (+)-Catechin and Dithiocarb on the Pharmacokinetics of Phenprocoumon, Tolbutamide and Three Inhalation Anesthetics in rats].
    Siegers CP; Iven H
    Arzneimittelforschung; 1982; 32(11):1437-40. PubMed ID: 6295415
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The metabolism of 1-phenyl-2-(N-methyl-N-furfurylamino)propane (furfenorex) in the rat in vivo and in vitro.
    Inoue T; Yasuda T; Suzuki S; Kishi T; Niwaguchi T
    Xenobiotica; 1986 Feb; 16(2):109-21. PubMed ID: 3962333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.